-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$17.50783.84% Upside
Immuneering Corporation Frequently Asked Questions
-
What analysts cover Immuneering Corporation?
Immuneering Corporation has been rated by research analysts at Mizuho Securities, Jefferies, Piper Sandler, Loop Capital Markets in the past 90 days.